Skip to content

Re-engaging Patients With Hepatitis C Into Care

Reengaging Patients With Previously Diagnosed Hepatitis C in to Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04029246
Enrollment
1000
Registered
2019-07-23
Start date
2019-11-01
Completion date
2020-08-01
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C, Chronic

Brief summary

Aims: To evaluate the impact of a letter, phone call and incentive in re-engaging patients with hepatitis C care. Outcomes of interest: Primary outcome of interest: \- Attendance for assessment of liver disease within 4 months of being sent invitation letter. Secondary outcomes of interest: \- Commencing treatment within 6 months of being sent invitation letter. Methods: Patient identification: The local copy of the Scottish Hepatitis C database holds data regarding patients referred to secondary care for treatment of their hepatitis C, and holds ethics approval for research on treatment and patient outcomes. This will be used to identify patients with hepatitis C infection that is untreated, treatment has been unsuccessful, or the patient has been treated but the outcome is unknown (due to non attendance for blood tests). The database has been cross checked with virus lab results, to ensure infection status is up to date. Finally, the patient data has been checked by NHS GG&C information team, to exclude patients who are deceased, or whom are no longer resident in NHS greater Glasgow and Clyde based on updated details obtained from SCIstore. Inclusion criteria: Patients (16 years and over) who have previously engaged with Hepatitis C services in Glasgow but who are either untreated, have been treated unsuccessfully, or have been treated but have not attended for blood tests to check for treatment success. Exclusion criteria: Patients with HIV. Patients no longer resident within NHS Greater Glasgow and Clyde area. Allocation to contact groups: Patients will be randomly distributed into 3 groups: 1. Letter: Will be sent letter 1 (appendix) 2. Letter plus telephone call: will be sent letter 2 (appendix) and be followed up with a telephone call from the treatment centre if no contact has been received after 4 weeks 3. Letter plus incentive: will be sent letter 3 (appendix) Process: Patient letters will be sent out by GG&C public health. For all 3 groups the letter will be sent with the small Hepatitis C Scotland booklet Hepatitis C treatments have changed. Letters will identify include the telephone number for the identified treatment centre which will be either, the last known treatment centre or a more local treatment centre were appropriate based on current residence. Primary and secondary outcomes measures will be collected via the Scottish Hepatitis C database. Lay Summary: This study will test whether a letter alone, a letter plus follow up phone call or a letter with offer of incentive, will be most effective in re-engaging patients who are known to have hepatitis C but not yet received treatment.

Interventions

BEHAVIORALFollow up phone call

Telephone call to ask if patient has received letter and whether they would like an appointment

BEHAVIORALIncentive

Offer of a shopping voucher if patient attends for appointment

Sponsors

Glasgow Caledonian University
CollaboratorOTHER
Glasgow Royal Infirmary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Age 16 years or older * Known hepatitis C infection which is either: * untreated * treated but the outcome of treatment unknown

Exclusion criteria

* Known HIV infection * No longer resident within NHS Greater Glasgow and Clyde area

Design outcomes

Primary

MeasureTime frameDescription
Rate of attendance for liver assessment4 monthsRates of attendance for assessment of liver disease within a 4 month period, recorded as a binary (yes/no) outcome

Secondary

MeasureTime frameDescription
Rates of initiation of Hepatitis C treatment6 monthsRates of initiation of treatment for hepatitis C within a 6 month period, recorded as a binary (yes/no) outcome.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026